|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-6-16
|
|
pubmed:abstractText |
We report the detailed expression profile of TRPM2 mRNA within the human central nervous system (CNS) and demonstrate increased TRPM2 mRNA expression at 1 and 4 weeks following ischemic injury in the rat transient middle cerebral artery occlusion (tMCAO) stroke model. Microglial cells play a key role in pathology produced following ischemic injury in the CNS and possess TRPM2, which may contribute to stroke-related pathological responses. We show that TRPM2 mRNA is present in the human C13 microglial cell line and is reduced by antisense treatment. Activation of C13 cells by interleukin-1beta leads to a fivefold increase of TRPM2 mRNA demonstrating transcriptional regulation. To confirm mRNA distribution correlated with functional expression, we combined electrophysiology, Ca2+ imaging, and antisense approaches. C13 microglia exhibited, when stimulated with hydrogen peroxide (H2O2), increased [Ca2+]i, which was reduced by antisense treatment. Moreover, patch-clamp recordings from C13 demonstrated that increased intracellular adenosine diphosphoribose (ADPR) or extracellular H2O2 induced an inward current, consistent with activation of TRPM2. In addition we confirm the functional expression of a TRPM2-like conductance in primary microglial cultures derived from rats. Activation of TRPM2 in microglia during ischemic brain injury may mediate key aspects of microglial pathophysiological responses.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1079-9893
|
|
pubmed:author |
pubmed-author:BenhamChristopher DCD,
pubmed-author:BrownJon TJT,
pubmed-author:CampbellColin ACA,
pubmed-author:CrookBarryB,
pubmed-author:FonfriaElenaE,
pubmed-author:HillKerstinK,
pubmed-author:MatteiCesarC,
pubmed-author:MaurioFrank PFP,
pubmed-author:McNultyShaunS,
pubmed-author:MurdockPaul RPR,
pubmed-author:OwenDavina EDE,
pubmed-author:RandallAndrewA,
pubmed-author:SkaperStephen DSD,
pubmed-author:TillingPaula LPL,
pubmed-author:WilsonJennifer MJM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
179-98
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16777714-Animals,
pubmed-meshheading:16777714-Base Sequence,
pubmed-meshheading:16777714-Calcium Signaling,
pubmed-meshheading:16777714-Cell Line,
pubmed-meshheading:16777714-Central Nervous System,
pubmed-meshheading:16777714-Disease Models, Animal,
pubmed-meshheading:16777714-Gene Expression Regulation,
pubmed-meshheading:16777714-Humans,
pubmed-meshheading:16777714-Hydrogen Peroxide,
pubmed-meshheading:16777714-Interleukin-1,
pubmed-meshheading:16777714-Male,
pubmed-meshheading:16777714-Microglia,
pubmed-meshheading:16777714-Middle Cerebral Artery,
pubmed-meshheading:16777714-RNA, Antisense,
pubmed-meshheading:16777714-RNA, Messenger,
pubmed-meshheading:16777714-Rats,
pubmed-meshheading:16777714-Rats, Sprague-Dawley,
pubmed-meshheading:16777714-Stroke,
pubmed-meshheading:16777714-TRPM Cation Channels,
pubmed-meshheading:16777714-Tissue Distribution
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
TRPM2 is elevated in the tMCAO stroke model, transcriptionally regulated, and functionally expressed in C13 microglia.
|
|
pubmed:affiliation |
Neurology and GI CEDD, GlaxoSmithKline, Harlow, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
